COVID-19: Russia's single-dose Sputnik Light vaccine has 79.4% efficacy, says RDIF - News Summed Up

COVID-19: Russia's single-dose Sputnik Light vaccine has 79.4% efficacy, says RDIF


The developers of the Russian COVID-19 vaccine Sputnik V on Thursday said that their single-dose Sputnik Light vaccine demonstrated 79.4 per cent efficacy against the COVID-19 and it has proven effective against all new strains of coronavirus. "The single-dose Sputnik Light vaccine demonstrated 79.4 percent efficacy according to analyzed data taken from 28 days after the injection was administered. "The Sputnik Light vaccine significantly reduces the possibility of severe cases leading to hospitalization, with only one injection needed. On February 21, the Gamaleya Center and RDIF launched a global efficacy study of Sputnik Light. "The cost of the Sputnik Light vaccine globally will be less than USD10, while it has simple storage requirements, at +2 +8, which provide for easy logistics.


Source: dna May 06, 2021 12:33 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */